FRANKLYN G PRENDERGAST Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for FRANKLYN G PRENDERGAST.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of FRANKLYN G PRENDERGAST. FRANKLYN G PRENDERGAST is a Director in LILLY ELI & CO ($LLY) and a Director in NeuBase Therapeutics, Inc. ($OHRP) and a Director in CANCER GENETICS, INC ($CGIX) and a Director in Lantern Pharma Inc. ($LTRN).

Address: LILLY CORPORATE CENTER INDIANAPOLIS 46285 IN

Companies in which FRANKLYN G PRENDERGAST is an Insider

ELI LILLY & Co

Trading Symbol: LLY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 68,574 shares
Current Value: $5,328,200
Latest Transaction: Nov 22 2017
$LLY Market Capitalization: $83.74B
$LLY Previous Close: $77.70

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Lantern Pharma Inc.

Trading Symbol: LTRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 0 shares
Latest Transaction: Jun 15 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

NeuBase Therapeutics, Inc.

Trading Symbol: NBSE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 11 2020
$NBSE Market Capitalization: $48.55M
$NBSE Previous Close: $1.35

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Vyant Bio, Inc.

Trading Symbol: CGIX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of FRANKLYN G PRENDERGAST: Director
Holdings: 12,500 shares
Current Value: $30,000
Latest Transaction: Aug 21 2019
$CGIX Market Capitalization: $42.50M
$CGIX Previous Close: $2.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of FRANKLYN G PRENDERGAST

Sentiment: All, LLY, LTRN, NBSE, CGIX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 11 2020OHRPNeuBase Therapeuti ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA8.8014,634128,77914,634
Jun 15 2020LTRNLantern Pharma Inc ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA15.009,135137,0259,135
Aug 21 2019CGIXCANCER GENETICS, I ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA0.15100,00015,000100,000
Jul 16 2019OHRPNeuBase Therapeuti ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA5.39227,3301,225,309227,330
Jul 16 2019OHRPNeuBase Therapeuti ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA5.39227,3301,225,309227,330
Nov 22 2017LLYLILLY ELI & COPRENDERGAST FRANKLYN GDirectorGrantA83.1880266,71068,57467.8 K to 68.6 K (+1.18 %)
Oct 02 2017CGIXCANCER GENETICS, I ...PRENDERGAST FRANKLYN GDirectorOption ExerciseA2.755,00013,7505,000

View all FRANKLYN G PRENDERGAST insider transactions.